Hideki Kasahara

A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19

Yohei Doi, Masaya Hibino, Ryota Hase et al. · Antimicrobial Agents and Chemotherapy · 2020 · 231 citations · Full text

Open-label Trial, Late Favipiravir Therapy, Clinical Infectious Disease +14

Proteolytic cleavage of β2-glycoprotein I: reduction of antigenicity and the structural relationship

Eiji Matsuura, Junko Inagaki, Hideki Kasahara et al. · International Immunology · 2000 · 34 citations · Full text

AP-VAS 2012 case report: an atypical case of microscopic polyangiitis presenting with acute tubulointerstitial nephritis without glomerular change

Hideki Kasahara, Hiroyuki Nakamura, Masahide Shinohara et al. · CEN Case Reports · 2013 · 13 citations · Full text

Glomerular Disease, Glomerulonephritis, Ap-vas 2012 +11

Calcineurin inhibitors for adult-onset Still's disease: a multicentre retrospective cohort study.

Hiroyuki Nakamura, Yuichiro Fujieda, Masato Tarumi et al. · PubMed · 2020 · 10 citations

Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo-controlled trial

Yuichiro Fujieda, Tetsuya Horita, Naoki Nishimoto et al. · Modern Rheumatology · 2020 · 10 citations